Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference

Attendees from 57 countries spend 2 days focused on advancing model-informed drug development

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, announced record-setting attendance and virtual content delivery for the 2022 MIDD+ Scientific Conference, which was held February 16-17, 2022. The conference focused on delivering real-world case studies using modeling and simulations. Tracks included dedicated sessions covering all stages of the drug development process, including Discovery, Pre-clinical, Clinical, and Post-approval/Generics.

Shawn O’Connor, chief executive officer of Simulations Plus, said: “We were pleased with the momentum that carried forward from our inaugural MIDD+ event last year, resulting in the record-setting attendance at this year’s MIDD+ Scientific Conference. As a leader in providing software tools and services to support the industry and our clients in their efforts to leverage modeling and simulation for more efficient and timely drug development, we were pleased to provide this virtual forum.”

The conference opened on February 16 with Rajanikanth Madabushi, PhD, Associate Director for Guidance and Scientific Policy, Office of Clinical Pharmacology, OTS/CDER, at the U.S. Food and Drug Administration (FDA), delivering his keynote talk entitled, “Advancing Model-Informed Drug Development (MIDD): A Holistic and Integrative Approach.” On day two, speakers worldwide, including representatives from the U.S. FDA, the Brazilian regulatory agency ANVISA, Health Canada, and MHRA-UK, provided attendees with case studies and global regulatory perspectives on the development and validation of MIDD.

Other session topics ranged from building and validating machine-learning models and using population PK/PD approaches to support late-phase dose selection. Of note, the Women in Science roundtable, led by Cognigen’s Divisional President, Jill Fiedler-Kelly, highlighted meaningful topics for women within the scientific pharmaceutical industry, including the power of mentorship, closing the STEM gap, and bringing your “authentic self” to the workplace. All talks are available for replay in the Simulations Plus Resource Center. Presentations and slide decks may be found on our website and YouTube channel.